HEADER TRANSFERASE/DNA 14-FEB-06 2G1P TITLE STRUCTURE OF E. COLI DNA ADENINE METHYLTRANSFERASE (DAM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*TP*CP*TP*AP*GP*AP*TP*CP*TP*AP*GP*A)-3'; COMPND 3 CHAIN: F, G; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: DNA ADENINE METHYLASE; COMPND 7 CHAIN: A, B; COMPND 8 SYNONYM: DEOXYADENOSYL-METHYLTRANSFERASE, DNA ADENINE COMPND 9 METHYLTRANSFERASE, M.ECODAM; COMPND 10 EC: 2.1.1.72; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 5 ORGANISM_TAXID: 562; SOURCE 6 GENE: DAM; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HMS174(DE3) KEYWDS DAM METHYLATION; GATC RECOGNITION; BASE FLIPPING; BACTERIAL VIRULENCE KEYWDS 2 FACTOR, TRANSFERASE-DNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.HORTON,K.LIEBERT,M.BEKES,A.JELTSCH,X.CHENG REVDAT 4 30-AUG-23 2G1P 1 REMARK REVDAT 3 13-JUL-11 2G1P 1 VERSN REVDAT 2 24-FEB-09 2G1P 1 VERSN REVDAT 1 21-NOV-06 2G1P 0 JRNL AUTH J.R.HORTON,K.LIEBERT,M.BEKES,A.JELTSCH,X.CHENG JRNL TITL STRUCTURE AND SUBSTRATE RECOGNITION OF THE ESCHERICHIA COLI JRNL TITL 2 DNA ADENINE METHYLTRANSFERASE. JRNL REF J.MOL.BIOL. V. 358 559 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16524590 JRNL DOI 10.1016/J.JMB.2006.02.028 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 303712.930 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 51126 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2437 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.92 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2123 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 116 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4001 REMARK 3 NUCLEIC ACID ATOMS : 486 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 314 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.07000 REMARK 3 B22 (A**2) : -9.00000 REMARK 3 B33 (A**2) : -3.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 35.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.010 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.010 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.580 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.820 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 51.28 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G1P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036577. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97179 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51126 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 33.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.57500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: GLRF REMARK 200 STARTING MODEL: MODIFIED PDB ENTRY 2DPM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM KCL, 10 MM MGSO4, 5-15% PEG400, REMARK 280 100 MM MES OR HEPES (PH 6.6-7.4), PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.65000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, G, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 SER A 188 REMARK 465 ALA A 189 REMARK 465 THR A 190 REMARK 465 ALA A 191 REMARK 465 ASN A 192 REMARK 465 PHE A 193 REMARK 465 THR A 194 REMARK 465 ALA A 195 REMARK 465 TYR A 196 REMARK 465 HIS A 197 REMARK 465 THR A 198 REMARK 465 VAL A 247 REMARK 465 ARG A 248 REMARK 465 ARG A 249 REMARK 465 SER A 250 REMARK 465 ILE A 251 REMARK 465 SER A 252 REMARK 465 SER A 253 REMARK 465 ASN A 254 REMARK 465 GLY A 255 REMARK 465 GLY A 256 REMARK 465 THR A 257 REMARK 465 ARG A 258 REMARK 465 LYS A 259 REMARK 465 GLY A 271 REMARK 465 VAL A 272 REMARK 465 VAL A 273 REMARK 465 SER A 274 REMARK 465 PRO A 275 REMARK 465 ALA A 276 REMARK 465 LYS A 277 REMARK 465 LYS A 278 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 SER B 188 REMARK 465 ALA B 189 REMARK 465 THR B 190 REMARK 465 ALA B 191 REMARK 465 ASN B 192 REMARK 465 PHE B 193 REMARK 465 THR B 194 REMARK 465 ALA B 195 REMARK 465 TYR B 196 REMARK 465 HIS B 197 REMARK 465 ARG B 248 REMARK 465 ARG B 249 REMARK 465 SER B 250 REMARK 465 ILE B 251 REMARK 465 SER B 252 REMARK 465 SER B 253 REMARK 465 ASN B 254 REMARK 465 GLY B 255 REMARK 465 GLY B 256 REMARK 465 THR B 257 REMARK 465 ARG B 258 REMARK 465 LYS B 259 REMARK 465 GLY B 271 REMARK 465 VAL B 272 REMARK 465 VAL B 273 REMARK 465 SER B 274 REMARK 465 PRO B 275 REMARK 465 ALA B 276 REMARK 465 LYS B 277 REMARK 465 LYS B 278 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 27 CG CD CE NZ REMARK 470 GLN A 75 CG CD OE1 NE2 REMARK 470 LEU A 187 CG CD1 CD2 REMARK 470 ASN A 199 CG OD1 ND2 REMARK 470 SER A 200 OG REMARK 470 MET A 231 CG SD CE REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 LYS A 246 CG CD CE NZ REMARK 470 LYS A 260 CG CD CE NZ REMARK 470 LEU B 187 CG CD1 CD2 REMARK 470 THR B 198 CG2 REMARK 470 MET B 231 CG SD CE REMARK 470 GLU B 235 CG CD OE1 OE2 REMARK 470 LYS B 246 CG CD CE NZ REMARK 470 LYS B 260 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 81 63.41 -102.23 REMARK 500 TYR A 119 109.81 -59.36 REMARK 500 LYS A 140 91.09 -160.29 REMARK 500 PHE B 81 65.37 -100.33 REMARK 500 ASN B 120 28.83 47.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 397 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FY3 RELATED DB: PDB REMARK 900 BACTERIOPHAGE T4DAM-ADOHCY-13-MER DNA REMARK 900 RELATED ID: 1YFJ RELATED DB: PDB REMARK 900 BACTERIOPHAGE T4DAM-ADOHCY-15-MER DNA REMARK 900 RELATED ID: 1YFL RELATED DB: PDB REMARK 900 BACTERIOPHAGE T4DAM-SINEFUNGIN-16-MER DNA REMARK 900 RELATED ID: 1Q0T RELATED DB: PDB REMARK 900 BACTERIOPHAGE T4DAM-ADOHY-DNA (NON-SPECIFIC) REMARK 900 RELATED ID: 1Q0S RELATED DB: PDB REMARK 900 BACTERIOPHAGE T4DAM-ADOHCY REMARK 999 REMARK 999 SEQUENCE AUTHOR STATES THAT RESIDUES 175 WERE MODELED AS SER REMARK 999 INSTEAD OF ALA FOR BOTH MOLECULES (CHAINS A AND B) BECAUSE OF REMARK 999 EXTRA DENSITY. DBREF 2G1P A 1 278 UNP P0AEE8 DMA_ECOLI 1 278 DBREF 2G1P B 1 278 UNP P0AEE8 DMA_ECOLI 1 278 DBREF 2G1P F 1 12 PDB 2G1P 2G1P 1 12 DBREF 2G1P G 1 12 PDB 2G1P 2G1P 1 12 SEQADV 2G1P SER A 175 UNP P0AEE8 ALA 175 SEE REMARK 999 SEQADV 2G1P SER B 175 UNP P0AEE8 ALA 175 SEE REMARK 999 SEQRES 1 F 12 DT DC DT DA DG DA DT DC DT DA DG DA SEQRES 1 G 12 DT DC DT DA DG DA DT DC DT DA DG DA SEQRES 1 A 278 MET LYS LYS ASN ARG ALA PHE LEU LYS TRP ALA GLY GLY SEQRES 2 A 278 LYS TYR PRO LEU LEU ASP ASP ILE LYS ARG HIS LEU PRO SEQRES 3 A 278 LYS GLY GLU CYS LEU VAL GLU PRO PHE VAL GLY ALA GLY SEQRES 4 A 278 SER VAL PHE LEU ASN THR ASP PHE SER ARG TYR ILE LEU SEQRES 5 A 278 ALA ASP ILE ASN SER ASP LEU ILE SER LEU TYR ASN ILE SEQRES 6 A 278 VAL LYS MET ARG THR ASP GLU TYR VAL GLN ALA ALA ARG SEQRES 7 A 278 GLU LEU PHE VAL PRO GLU THR ASN CYS ALA GLU VAL TYR SEQRES 8 A 278 TYR GLN PHE ARG GLU GLU PHE ASN LYS SER GLN ASP PRO SEQRES 9 A 278 PHE ARG ARG ALA VAL LEU PHE LEU TYR LEU ASN ARG TYR SEQRES 10 A 278 GLY TYR ASN GLY LEU CYS ARG TYR ASN LEU ARG GLY GLU SEQRES 11 A 278 PHE ASN VAL PRO PHE GLY ARG TYR LYS LYS PRO TYR PHE SEQRES 12 A 278 PRO GLU ALA GLU LEU TYR HIS PHE ALA GLU LYS ALA GLN SEQRES 13 A 278 ASN ALA PHE PHE TYR CYS GLU SER TYR ALA ASP SER MET SEQRES 14 A 278 ALA ARG ALA ASP ASP SER SER VAL VAL TYR CYS ASP PRO SEQRES 15 A 278 PRO TYR ALA PRO LEU SER ALA THR ALA ASN PHE THR ALA SEQRES 16 A 278 TYR HIS THR ASN SER PHE THR LEU GLU GLN GLN ALA HIS SEQRES 17 A 278 LEU ALA GLU ILE ALA GLU GLY LEU VAL GLU ARG HIS ILE SEQRES 18 A 278 PRO VAL LEU ILE SER ASN HIS ASP THR MET LEU THR ARG SEQRES 19 A 278 GLU TRP TYR GLN ARG ALA LYS LEU HIS VAL VAL LYS VAL SEQRES 20 A 278 ARG ARG SER ILE SER SER ASN GLY GLY THR ARG LYS LYS SEQRES 21 A 278 VAL ASP GLU LEU LEU ALA LEU TYR LYS PRO GLY VAL VAL SEQRES 22 A 278 SER PRO ALA LYS LYS SEQRES 1 B 278 MET LYS LYS ASN ARG ALA PHE LEU LYS TRP ALA GLY GLY SEQRES 2 B 278 LYS TYR PRO LEU LEU ASP ASP ILE LYS ARG HIS LEU PRO SEQRES 3 B 278 LYS GLY GLU CYS LEU VAL GLU PRO PHE VAL GLY ALA GLY SEQRES 4 B 278 SER VAL PHE LEU ASN THR ASP PHE SER ARG TYR ILE LEU SEQRES 5 B 278 ALA ASP ILE ASN SER ASP LEU ILE SER LEU TYR ASN ILE SEQRES 6 B 278 VAL LYS MET ARG THR ASP GLU TYR VAL GLN ALA ALA ARG SEQRES 7 B 278 GLU LEU PHE VAL PRO GLU THR ASN CYS ALA GLU VAL TYR SEQRES 8 B 278 TYR GLN PHE ARG GLU GLU PHE ASN LYS SER GLN ASP PRO SEQRES 9 B 278 PHE ARG ARG ALA VAL LEU PHE LEU TYR LEU ASN ARG TYR SEQRES 10 B 278 GLY TYR ASN GLY LEU CYS ARG TYR ASN LEU ARG GLY GLU SEQRES 11 B 278 PHE ASN VAL PRO PHE GLY ARG TYR LYS LYS PRO TYR PHE SEQRES 12 B 278 PRO GLU ALA GLU LEU TYR HIS PHE ALA GLU LYS ALA GLN SEQRES 13 B 278 ASN ALA PHE PHE TYR CYS GLU SER TYR ALA ASP SER MET SEQRES 14 B 278 ALA ARG ALA ASP ASP SER SER VAL VAL TYR CYS ASP PRO SEQRES 15 B 278 PRO TYR ALA PRO LEU SER ALA THR ALA ASN PHE THR ALA SEQRES 16 B 278 TYR HIS THR ASN SER PHE THR LEU GLU GLN GLN ALA HIS SEQRES 17 B 278 LEU ALA GLU ILE ALA GLU GLY LEU VAL GLU ARG HIS ILE SEQRES 18 B 278 PRO VAL LEU ILE SER ASN HIS ASP THR MET LEU THR ARG SEQRES 19 B 278 GLU TRP TYR GLN ARG ALA LYS LEU HIS VAL VAL LYS VAL SEQRES 20 B 278 ARG ARG SER ILE SER SER ASN GLY GLY THR ARG LYS LYS SEQRES 21 B 278 VAL ASP GLU LEU LEU ALA LEU TYR LYS PRO GLY VAL VAL SEQRES 22 B 278 SER PRO ALA LYS LYS HET SAH A 401 26 HET SAH B 402 26 HET GOL B 397 6 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 SAH 2(C14 H20 N6 O5 S) FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *314(H2 O) HELIX 1 1 LYS A 14 PRO A 16 5 3 HELIX 2 2 LEU A 17 LEU A 25 1 9 HELIX 3 3 GLY A 39 ASN A 44 1 6 HELIX 4 4 ASN A 56 ARG A 69 1 14 HELIX 5 5 ARG A 69 GLU A 79 1 11 HELIX 6 6 LEU A 80 PHE A 81 5 2 HELIX 7 7 VAL A 82 ASN A 86 5 5 HELIX 8 8 CYS A 87 SER A 101 1 15 HELIX 9 9 ASP A 103 GLY A 118 1 16 HELIX 10 10 TYR A 119 LEU A 122 5 4 HELIX 11 11 PRO A 144 ALA A 155 1 12 HELIX 12 12 SER A 164 ALA A 170 1 7 HELIX 13 13 THR A 202 ARG A 219 1 18 HELIX 14 14 THR A 230 TYR A 237 1 8 HELIX 15 15 LYS B 14 PRO B 16 5 3 HELIX 16 16 LEU B 17 LEU B 25 1 9 HELIX 17 17 GLY B 39 ASN B 44 1 6 HELIX 18 18 ASN B 56 ARG B 69 1 14 HELIX 19 19 ARG B 69 GLU B 79 1 11 HELIX 20 20 LEU B 80 PHE B 81 5 2 HELIX 21 21 VAL B 82 ASN B 86 5 5 HELIX 22 22 CYS B 87 SER B 101 1 15 HELIX 23 23 ASP B 103 GLY B 118 1 16 HELIX 24 24 TYR B 119 LEU B 122 5 4 HELIX 25 25 PRO B 144 ALA B 155 1 12 HELIX 26 26 SER B 164 ALA B 170 1 7 HELIX 27 27 THR B 202 ARG B 219 1 18 HELIX 28 28 THR B 230 TYR B 237 1 8 SHEET 1 A 7 ALA A 158 CYS A 162 0 SHEET 2 A 7 ARG A 49 ASP A 54 1 N LEU A 52 O PHE A 159 SHEET 3 A 7 CYS A 30 GLU A 33 1 N GLU A 33 O ALA A 53 SHEET 4 A 7 SER A 176 CYS A 180 1 O VAL A 177 N VAL A 32 SHEET 5 A 7 VAL A 223 HIS A 228 1 O LEU A 224 N CYS A 180 SHEET 6 A 7 GLU A 263 TYR A 268 -1 O TYR A 268 N VAL A 223 SHEET 7 A 7 LYS A 241 VAL A 245 -1 N VAL A 245 O GLU A 263 SHEET 1 B 7 ALA B 158 CYS B 162 0 SHEET 2 B 7 ARG B 49 ASP B 54 1 N LEU B 52 O PHE B 159 SHEET 3 B 7 CYS B 30 GLU B 33 1 N GLU B 33 O ALA B 53 SHEET 4 B 7 SER B 176 CYS B 180 1 O TYR B 179 N VAL B 32 SHEET 5 B 7 VAL B 223 HIS B 228 1 O LEU B 224 N CYS B 180 SHEET 6 B 7 GLU B 263 TYR B 268 -1 O TYR B 268 N VAL B 223 SHEET 7 B 7 LYS B 241 VAL B 245 -1 N VAL B 245 O GLU B 263 SITE 1 AC1 18 TRP A 10 LYS A 14 PRO A 34 PHE A 35 SITE 2 AC1 18 VAL A 36 GLY A 37 ALA A 38 GLY A 39 SITE 3 AC1 18 SER A 40 ASP A 54 ILE A 55 SER A 164 SITE 4 AC1 18 TYR A 165 ASP A 181 PRO A 183 HOH A 403 SITE 5 AC1 18 HOH A 409 HOH A 448 SITE 1 AC2 19 TRP B 10 LYS B 14 PRO B 34 PHE B 35 SITE 2 AC2 19 VAL B 36 GLY B 37 ALA B 38 GLY B 39 SITE 3 AC2 19 SER B 40 ASP B 54 ILE B 55 SER B 164 SITE 4 AC2 19 TYR B 165 ASP B 181 HOH B 404 HOH B 410 SITE 5 AC2 19 HOH B 429 HOH B 457 HOH B 518 SITE 1 AC3 7 TRP B 10 ALA B 11 GLY B 121 LEU B 122 SITE 2 AC3 7 CYS B 123 HOH B 429 HOH B 479 CRYST1 46.200 71.300 97.800 90.00 90.03 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021638 -0.000001 0.000011 0.00000 SCALE2 0.000000 0.014020 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010226 0.00000